Loading organizations...
Libre Foods specializes in developing fungi-based meat alternatives, leveraging biotechnology to create sustainable protein products. The company focuses on mycelium, the root structure of mushrooms, to engineer prototypes that replicate the texture and taste of conventional meats, including bacon and whole-cut chicken. Their technical approach centers on biomass fermentation to produce innovative, planet-friendly food solutions.
The Spanish biotech startup was founded by Alan Iván Ramos and is based in Barcelona. Ramos established Libre Foods with the core insight that fungi, particularly mycelium, offer a powerful and sustainable pathway to reinvent the food system. His vision centered on harnessing nature's efficiency to address environmental challenges associated with traditional animal agriculture.
Libre Foods targets consumers seeking sustainable and ethical protein choices. The company's overarching mission is to transform the global food system by providing accessible and delicious fungi-based alternatives. This forward-looking vision aims to establish fungi as a fundamental ingredient for a more resilient and liberated food future.
Libre Foods has raised $2.7M across 3 funding rounds.
Libre Foods has raised $2.7M in total across 3 funding rounds.
Libre Foods is a Barcelona-based biotechnology startup that develops fungi-based mycelium ingredients and whole-cut meat alternatives (e.g., fungi-derived bacon) aimed at replacing animal meat with fermented mycoprotein products for consumers and food manufacturers[1][3][2].
High-Level Overview
For the product-centric view (portfolio company style): Libre builds mycelium-derived food products and an AI-enabled discovery/R&D platform to accelerate strain and ingredient development, serving food manufacturers, retailers, and consumers seeking meat alternatives[1][2][3]. Its core problem solved is producing scalable, flavorful, texture‑accurate meat analogs using fungal fermentation to reduce reliance on animal agriculture while aiming for competitive cost and nutritional profiles[1][3]. Reported growth momentum included product launches (notably EU “fungi‑based bacon”) and follow-on funding rounds and industry partnerships that culminated in the acquisition of core assets by Swiss biomanufacturing firm Planetary SA to scale industrialization[2][1].
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick take: Libre Foods was an ambitious European fungi‑first food biotech that moved from product launches and a high‑throughput R&D platform to becoming a strategic acquisition target for industrial‑scale biomanufacturing—its legacy is the IP and proof points that now aim to scale mycelium‑based meat alternatives across Europe[2][1].
Libre Foods has raised $2.7M across 3 funding rounds. Most recently, it raised $370K Grant in December 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 19, 2023 | $370K Grant | European Investment Fund | — | Announced |
| Feb 1, 2022 | $2M Seed | — | Green Generation Fund, Arman Anatürk, Arturo Elizondo, David Brandes, Ritu Bansal Mutalik, ProVeg International, Matthew Glover | Announced |
| Dec 1, 2020 | $300K Seed | — | Babel Ventures, ExSight Capital Management, Mayfield, Social Starts, SOSV | Announced |
Libre Foods has raised $2.7M in total across 3 funding rounds.
Libre Foods's investors include European Investment Fund, Green Generation Fund, Arman Anatürk, Arturo Elizondo, David Brandes, Ritu Bansal-Mutalik, ProVeg International, Matthew Glover, Babel Ventures, ExSight Capital Management, Mayfield, Social Starts.